FDAapproval65% confidence
Prescription Drug User Fee Amendments
Source: FDA
Why This Matters
Why this matters: provides agency context on approval that may shape timing or evidence expectations for biologics manufacturers.
Regulatory Analysis
The Prescription Drug User Fee Act (PDUFA) was created by Congress in 1992 and authorizes FDA to collect fees from companies that produce certain human drug and biological products. Since the passage of PDUFA, user fees have played an important role in expediting the drug approval process.
Supporting Context
- Therapeutic area
- Biologics · Drug Delivery
- Sub-indication
- General
Related signal: Advancements in Subcutaneous Drug Delivery for High Concentration Antibody Products